Open AccessPP16. ANGIOTENSIN SIGNALLING IN GBM: AT2R AS A NOVEL THERAPEUTIC TARGET
Author(s) -
Mr Alexander Renziehausen,
Dr Jennifer Eschbacher,
Dr Andreas Tzakos,
Dr Kevin O’Neill,
Dr Tim Crook,
Dr Nelofer Syed
Publication year - 2017
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now293.015
Subject(s) - losartan , angiogenesis , angiotensin ii , renin–angiotensin system , cancer research , cell growth , pharmacology , angiotensin receptor , losartan potassium , receptor , medicine , chemistry , blood pressure , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom